Pharmaceuticals

    Biofarm: ESG That Starts with Data and Ends with Strategy

    Biofarm
    Biofarm: ESG That Starts with Data and Ends with Strategy

    Biofarm’s collaboration with Envirly by Quantifier demonstrates an ESG approach built around what truly determines success: reliable data, clear accountability, and a repeatable process.

    Biofarm is one of the largest pharmaceutical companies with Polish capital. For over 35 years, it has consistently invested in growth, innovation, and new technologies, basing its operations on cooperation with top-tier experts.

    The company operates its own Research and Development Center, where a highly qualified team works every day on modern therapeutic solutions, often launched first on the Polish market. As much as 80% of its portfolio consists of proprietary formulations, confirming Biofarm’s strong scientific capabilities and innovative profile. More than 93% of its medicines are manufactured in a modern production facility in Poznań, ensuring full control over quality, safety, and the manufacturing process.

    • Industry: Pharmaceuticals (manufacturing and development of medicinal products)

    • Headquarters and manufacturing: Poznań, Poland

    • Scale: Large enterprise (250+ employees)

    • Markets: Poland plus exports (products available in approx. 30 countries)

    • Innovation profile: In-house R&D Center, 80% proprietary formulations, 93%+ manufacturing in Poznań

    Biofarm: Responsibility Embedded in Strategy

    Biofarm decided to prepare a sustainability (ESG) report based on a strong sense of social responsibility and the belief that people should remain at the center of all actions. Its products serve patients, while parallel initiatives focus on minimizing the company’s negative impact on the environment in which people live.

    The company’s operations are grounded in respect for employees, business partners, and contractors. Fair play, transparency, and relationships built on mutual trust form the foundation of collaboration and long-term growth. In this context, ESG becomes a way to structure what the organization is already doing and a tool for consistently managing its impact. Biofarm also communicates its strategic approach to ESG in public materials, ensuring that its narrative aligns with real actions and implementation processes.

    A Structured Approach to ESG Reporting: Implementing Envirly ESG and Envirly GHG

    Biofarm’s ESG reporting readiness process was built around establishing an interdisciplinary task force responsible for identifying and defining the scope of key activities across the company’s most important areas. The team’s work focused on the three ESG pillars: environmental, social, and governance. On the Envirly by Quantifier side, the foundation was the creation of an organizational framework for collecting and processing data. In the first phase, consultant support was also important, particularly in the area of double materiality assessment.

    In practice, this “framework” means:

    • a clear division of roles: data owners, approvers, and data providers within business units,

    • standardized data definitions (so the same term does not mean five different things across five departments),

    • a defined flow of information and evidence (an audit trail),

    • mechanisms for working with contractors on value chain data.

    The biggest challenge was collecting value chain data, especially emissions that are not generated directly within the organization but must be obtained from contractors.

    This process involves not only mapping suppliers and business partners and identifying data streams (who provides what data, how often, and in what format), but also defining a minimum, methodologically sound scope of information. The Envirly platform supported a structured approach to managing ESG data across the entire value chain.

    In the pharmaceutical sector, the importance of this approach is further amplified by high operational sensitivity, including supply continuity, rigorous quality requirements, and the need for full auditability of processes. As a result, ESG must function as a permanent management system integrated into day-to-day operations, not as a one-off reporting exercise.

    ESG Reporting as Decision Discipline and Market Readiness, the Kind Every CFO Actually Needs

    Biofarm treats ESG reporting as a multi-year process. It is intended to help identify areas with the greatest impact on the environment and stakeholders, and then address them systematically, moving toward climate neutrality and greater social responsibility.

    At this stage, the most important “hard” outcomes companies typically see include:

    • moving from intuition to priorities based on materiality and data,

    • improving internal coordination (who is responsible for E/S/G),

    • increasing maturity in working with supplier and contractor data (Scope 3),

    • real readiness for further transformation, instead of “putting out fires” to meet reporting deadlines.

    In short: ESG stops being a narrative and becomes a management mechanism.

    Takeaways for Companies: How to Start Without Getting Stuck in Data Collection

    Biofarm’s ESG approach is rooted in high standards of professionalism and ethics, where people and deliberately designed processes play a central role. The company initiated work in this area early, before it became subject to formal regulatory obligations. This created space for calm analysis, identifying areas requiring reinforcement, and gradually building a mature ESG management system without deadline pressure.

    “It is important to create an internal team within the company to initiate the work. It is also a good practice to prepare a report before legal requirements take effect.”

    Companies that handle ESG well treat data like a product: with a definition, an owner, a quality standard, and a lifecycle.

    Summary

    Biofarm’s collaboration with Envirly by Quantifier demonstrates an ESG approach grounded in what truly determines success: data, accountability, and a repeatable process. Biofarm started by building a team and organizing the scope of activities across E, S, and G. Envirly by Quantifier supported the organization in establishing a framework for collecting and processing ESG data and conducting a double materiality assessment, helping transform reporting into a tool for long-term management of impact and priorities.

    Contact Us

    If you want to organize ESG in your company, reduce the time required to collect data, standardize cooperation with suppliers, and build a process that will work in the years to come, contact Envirly by Quantifier.